DGFT extended the dt for implementation of Track system for export of drug formulations till Mar 23

The DGFT vide Public Notice No. 01/2015-20 dated April 04, 2022 has extended the date for implementation of the Track and Trace system for export of drug formulations w.r.t. maintaining the Parent-Child relationship in packaging levels and its uploading on Central Portal for both SSI and non SSI manufactured drugs till March 31, 2023.

In exercise of the powers conferred under Paragraph 2.04 of the Foreign Trade Policy, 2015-20, as amended from time-to-time, the Director General of Foreign ‘Trade hereby amends Para 2.90A of Handbook of Procedure- 2015-20, as notified vide Public Notice No. 43/2015-20 dated December 05, 2017 read with Public Notice No. 52 / 2015-20 dated January 05, 2016, Public Notice No. 05/2015-20 dated May 09, 2018, Public Notice No. 43/2015- 2020 dated November 01, 2018, Public Notice No. 16/2015- 2020 dated July 04, 2019, Public Notice No. 66/2015- 2020 dated March 30, 2019, Public Notice No. 16/2015-2020 dated September 22, 2020 and Public Notice No. 46/2015-20 dated March 31, 2021 on laying down the procedure for implementation of the Track and Trace system for export consignments of drug formulations.

In Para 2.90 A (vi) and (vii) of Handbook of Procedure - 2015-20 (as amended vide Public Notice No. 46/2015-20 dated March 30, 2021), “April 01, 2022” may be substituted by “March 31, 2023”.

Effect of this Public Notice: The date for implementation of Track and Trace system for export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and its uploading on Central Portal has been extended up to March 31, 2023 for both SSI and non SSI manufactured drugs.

The publice notice can be access at - https://content.dgft.gov.in/Website/dgftprod/84def606-a992-446c-853d-9f2f303fc0b1/PN%2001.pdf